Therapeutic activity of sarpogrelate and dopamine D2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes
Abstract Background Dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia. An affiliation was found between the initiation of myocardial injury ailment and long term treatment with dopamine D2 ago...
Saved in:
Main Authors: | Mohammed Ahmed Fouad Shalaby (Author), Hekma A. Abd El Latif (Author), Mohamed El Yamani (Author), May Ahmed Galal (Author), Sherifa Kamal (Author), Ikhlas Sindi (Author), Raneem Masaood (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647]
by: Mohammed Fouad Shalaby, et al.
Published: (2022) -
Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats
by: Mohammed Fouad Shalaby, MD, et al.
Published: (2021) -
Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
by: Saida Abdel Regal Aly, et al.
Published: (2009) -
Inverse Agonist Activity of Sarpogrelate, a Selective 5-HT2A-Receptor Antagonist, at the Constitutively Active Human 5-HT2A Receptor
by: Habib Abul Muntasir, et al.
Published: (2006) -
Interaction of glimepiride with prokinetic drugs on some of gastrointestinal functions in STZ-induced diabetic mice
by: Mohamed A. Fouad, et al.
Published: (2013)